眼部弓形虫病的表现与管理 - Suppr

Suppr

超能文献

Manifestations and management of ocular toxoplasmosis.

作者信息

O'Connor G R

出版信息

Bull N Y Acad Med. 1974 Feb;50(2):192-210.

PMID:4521729

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1749344/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c563/1749344/e525539db9da/bullnyacadmed00169-0091-a.jpg

相似文献

Manifestations and management of ocular toxoplasmosis.

Bull N Y Acad Med. 1974 Feb;50(2):192-210.

Clindamycin effects on experimental ocular toxoplasmosis in the rabbit.

Arch Ophthalmol. 1974 Sep;92(3):244-7. doi: 10.1001/archopht.1974.01010010252017.

Ocular toxoplasmosis treatment and clinical monitoring of the patient.

J Am Optom Assoc. 1982 Jul;53(7):535-40.

The treatment of toxoplasmic posterior uveitis (chorioretinitis).

Am J Med Sci. 1966 Feb;251(2):241-2.

[Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].

J Fr Ophtalmol. 1990;13(11-12):551-3.

Variations in recurrent active toxoplasmic retinochoroiditis.

Arch Ophthalmol. 1969 Apr;81(4):481-93. doi: 10.1001/archopht.1969.00990010483005.

[Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].

J Fr Ophtalmol. 1989;12(3):161-5.

Treatment of active toxoplasmic retino-choroiditis.

Br J Ophthalmol. 1968 May;52(5):396-9. doi: 10.1136/bjo.52.5.396.

Recurrent toxoplasmic retinochoroiditis after clindamycin: a case report.

Ann Ophthalmol. 1982 Jul;14(7):632-3.

[An analysis of the treatment and evolution of 56 cases of ocular toxoplasmosis].

Bol Chil Parasitol. 1966 Oct-Dec;21(4):108-11.

引用本文的文献

Toxoplasma gondii bradyzoites and tachyzoites isolation from vitreous of atypical necrotizing retinitis.

J Ophthalmic Inflamm Infect. 2018 Jun 15;8(1):8. doi: 10.1186/s12348-018-0151-x.

Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD007417. doi: 10.1002/14651858.CD007417.pub3.

Severe ocular sequelae of congenital toxoplasmosis: huge macular scar.

Pan Afr Med J. 2015 Mar 12;20:233. doi: 10.11604/pamj.2015.20.233.5097. eCollection 2015.

Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.

PLoS Negl Trop Dis. 2016 May 2;10(5):e0004685. doi: 10.1371/journal.pntd.0004685. eCollection 2016 May.

Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Cochrane Database Syst Rev. 2013 Apr 30;4(4):CD007417. doi: 10.1002/14651858.CD007417.pub2.

Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.

Int Ophthalmol. 2012 Dec;32(6):539-45. doi: 10.1007/s10792-012-9599-0. Epub 2012 Jun 26.

Why prevent, diagnose and treat congenital toxoplasmosis?

Mem Inst Oswaldo Cruz. 2009 Mar;104(2):320-44. doi: 10.1590/s0074-02762009000200029.

Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography.

Br J Ophthalmol. 2007 Jun;91(6):773-80. doi: 10.1136/bjo.2006.108068. Epub 2006 Nov 29.

Fungal and parasitic infections of the eye.

Clin Microbiol Rev. 2000 Oct;13(4):662-85. doi: 10.1128/CMR.13.4.662.

The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.

Trans Am Ophthalmol Soc. 1998;96:813-79.

本文引用的文献

HUMAN TOXOPLASMOSIS: OCCURRENCE IN INFANTS AS AN ENCEPHALOMYELITIS VERIFICATION BY TRANSMISSION TO ANIMALS.

Science. 1939 Mar 10;89(2306):226-7. doi: 10.1126/science.89.2306.226.

Toxoplasma chorioretinitis in adults.

AMA Arch Ophthalmol. 1952 Aug;48(2):127-36. doi: 10.1001/archopht.1952.00920010132001.

Immunogenic endophthalmitis produced in the guinea pig by different pathogenetic mechanisms.

Am J Ophthalmol. 1959 Nov;48(5)Pt 2:435-47. doi: 10.1016/0002-9394(59)90596-3.

CONNATAL OCULAR TOXOPLASMOSIS.

Arch Ophthalmol. 1965 Jul;74:48-54. doi: 10.1001/archopht.1965.00970040050012.

OCULAR TOXOPLASMOSIS.

Arch Ophthalmol. 1964 Nov;72:592-600. doi: 10.1001/archopht.1964.00970020592003.

THERAPY OF TOXOPLASMIC RETINOCHOROIDITIS.

Arch Ophthalmol. 1964 Jun;71:883-5. doi: 10.1001/archopht.1964.00970010899023.

TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY.

Arch Ophthalmol. 1964 Jan;71:58-62. doi: 10.1001/archopht.1964.00970010074010.

Active neuro-ophthalmic toxoplasmosis. A clinical study on nineteen patients.

Bibl Ophthalmol. 1962;59:265-343.

Penetration of pyrimethamine (daraprim) into ocular tissues of rabbits.

AMA Arch Ophthalmol. 1958 Oct;60(4 Part 1):603-11. doi: 10.1001/archopht.1958.00940080623008.

Recovery of toxoplasma from a human eye.

AMA Arch Ophthalmol. 1958 Oct;60(4 Part 1):548-54. doi: 10.1001/archopht.1958.00940080566004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Manifestations and management of ocular toxoplasmosis.

Bull N Y Acad Med. 1974 Feb;50(2):192-210.

Clindamycin effects on experimental ocular toxoplasmosis in the rabbit.

Arch Ophthalmol. 1974 Sep;92(3):244-7. doi: 10.1001/archopht.1974.01010010252017.

Ocular toxoplasmosis treatment and clinical monitoring of the patient.

J Am Optom Assoc. 1982 Jul;53(7):535-40.

The treatment of toxoplasmic posterior uveitis (chorioretinitis).

Am J Med Sci. 1966 Feb;251(2):241-2.

[Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].

J Fr Ophtalmol. 1990;13(11-12):551-3.

Variations in recurrent active toxoplasmic retinochoroiditis.

Arch Ophthalmol. 1969 Apr;81(4):481-93. doi: 10.1001/archopht.1969.00990010483005.

[Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].

J Fr Ophtalmol. 1989;12(3):161-5.

Treatment of active toxoplasmic retino-choroiditis.

Br J Ophthalmol. 1968 May;52(5):396-9. doi: 10.1136/bjo.52.5.396.

Recurrent toxoplasmic retinochoroiditis after clindamycin: a case report.

Ann Ophthalmol. 1982 Jul;14(7):632-3.

[An analysis of the treatment and evolution of 56 cases of ocular toxoplasmosis].

Bol Chil Parasitol. 1966 Oct-Dec;21(4):108-11.

引用本文的文献

Toxoplasma gondii bradyzoites and tachyzoites isolation from vitreous of atypical necrotizing retinitis.

J Ophthalmic Inflamm Infect. 2018 Jun 15;8(1):8. doi: 10.1186/s12348-018-0151-x.

Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD007417. doi: 10.1002/14651858.CD007417.pub3.

Severe ocular sequelae of congenital toxoplasmosis: huge macular scar.

Pan Afr Med J. 2015 Mar 12;20:233. doi: 10.11604/pamj.2015.20.233.5097. eCollection 2015.

Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.

PLoS Negl Trop Dis. 2016 May 2;10(5):e0004685. doi: 10.1371/journal.pntd.0004685. eCollection 2016 May.

Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Cochrane Database Syst Rev. 2013 Apr 30;4(4):CD007417. doi: 10.1002/14651858.CD007417.pub2.

Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.

Int Ophthalmol. 2012 Dec;32(6):539-45. doi: 10.1007/s10792-012-9599-0. Epub 2012 Jun 26.

Why prevent, diagnose and treat congenital toxoplasmosis?

Mem Inst Oswaldo Cruz. 2009 Mar;104(2):320-44. doi: 10.1590/s0074-02762009000200029.

Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography.

Br J Ophthalmol. 2007 Jun;91(6):773-80. doi: 10.1136/bjo.2006.108068. Epub 2006 Nov 29.

Fungal and parasitic infections of the eye.

Clin Microbiol Rev. 2000 Oct;13(4):662-85. doi: 10.1128/CMR.13.4.662.

The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.

Trans Am Ophthalmol Soc. 1998;96:813-79.

本文引用的文献

HUMAN TOXOPLASMOSIS: OCCURRENCE IN INFANTS AS AN ENCEPHALOMYELITIS VERIFICATION BY TRANSMISSION TO ANIMALS.

Science. 1939 Mar 10;89(2306):226-7. doi: 10.1126/science.89.2306.226.

Toxoplasma chorioretinitis in adults.

AMA Arch Ophthalmol. 1952 Aug;48(2):127-36. doi: 10.1001/archopht.1952.00920010132001.

Immunogenic endophthalmitis produced in the guinea pig by different pathogenetic mechanisms.

Am J Ophthalmol. 1959 Nov;48(5)Pt 2:435-47. doi: 10.1016/0002-9394(59)90596-3.

CONNATAL OCULAR TOXOPLASMOSIS.

Arch Ophthalmol. 1965 Jul;74:48-54. doi: 10.1001/archopht.1965.00970040050012.

OCULAR TOXOPLASMOSIS.

Arch Ophthalmol. 1964 Nov;72:592-600. doi: 10.1001/archopht.1964.00970020592003.

THERAPY OF TOXOPLASMIC RETINOCHOROIDITIS.

Arch Ophthalmol. 1964 Jun;71:883-5. doi: 10.1001/archopht.1964.00970010899023.

TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY.

Arch Ophthalmol. 1964 Jan;71:58-62. doi: 10.1001/archopht.1964.00970010074010.

Active neuro-ophthalmic toxoplasmosis. A clinical study on nineteen patients.

Bibl Ophthalmol. 1962;59:265-343.

Penetration of pyrimethamine (daraprim) into ocular tissues of rabbits.

AMA Arch Ophthalmol. 1958 Oct;60(4 Part 1):603-11. doi: 10.1001/archopht.1958.00940080623008.

Recovery of toxoplasma from a human eye.

AMA Arch Ophthalmol. 1958 Oct;60(4 Part 1):548-54. doi: 10.1001/archopht.1958.00940080566004.